Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Clinical Pharmacy
CP-048
ANALYSIS OF THE AMBULATORY USE OF BOTULINUM TOXIN TYPE A IN A TERTIARY HOSPITAL: AUTHORIZED AND OFF-LABEL INDICATIONS
CP-047
PHARMACIST'S CONTRIBUTION TO THE OPTIMIZATION OF DRUG THERAPY IN ONCOLOGY INPATIENTS
CP-046
HYPERSENSITIVITY REACTIONS TO CHEMOTHERAPY: SO... WHAT DO WE DO NOW?
CP-045
ELECTRONIC PRESCRIBING: THE DEVELOPMENT OF A PAEDIATRIC DRUG DATABASE
CP-044
EFFECTIVENESS AND SAFETY OF IMATINIB IN CHRONIC MYELOID LEUKEMIA IN A TERTIARY HOSPITAL
CP-043
IMPLEMENTATION OF EXTENDED TOP-UP SERVICE INCREASED CORRECT RECORDING IN THE ELECTRONIC MEDICATION MODULE
CP-040
SWITCHING TO TENOFOVIR/ EMTRICITABINE/RILPIVIRINE IN HIV-1 PATIENTS PREVIOUSLY TREATED WITH TENOFOVIR/EMTRICITABINE/EFAVIRENZ
CP-038
ADEQUACY OF NUTRITION ENERGY DELIVERY IN SURGICAL INTENSIVE CARE
CP-037
EFICACY OF ABIRATERONE IN THE TREATMENT OF PROSTATE CANCER
CP-036
DRUG INTERACTIONS INVOLVING ANTIBIOTICS: DO THEY CARE?
CP-034
IPILIMUMAB EXPERIENCE IN ADVANCED MELANOMA
CP-033
USE OF INFLIXIMAB IN A PREGNANT WOMAN WITH ANKYLOSING SPONDYLITIS
CP-032
OFF-LABEL USE OF ADALIMUMAB IN BEHÇET'S DISEASE. A CASE REPORT
CP-027
EFFICACY AND SAFETY OF RIBAVIRIN USED FOR RESPIRATORY SYNCITIAL VIRUS TREATMENT IN HEMATOLOGICAL PATIENTS
CP-026
EFFICACY OF TRIPLE THERAPY WITH PROTEASE INHIBITORS FOR THE TREATMENTOF HEPATITIS C VIRUS IN CLINICAL PRACTICE
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »
Follow Us